Cargando…
The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori
BACKGROUND: Helicobacter pylori (HP) infection causes many diseases, such as peptic ulcers, gastritis and gastric cancer, and MALToma. It has been gradually accepted that all HP-infected patients should be treated because HP is regarded as an infection. Therefore, the importance of selecting the opt...
Autores principales: | Lee, Seung Woo, Moon, Sung Jin, Kim, Sae Hee, Jung, Sung Hee, Song, Kyung Ho, Kim, Sun Moon, Sung, Jae Kyu, Lee, Dong Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505311/ https://www.ncbi.nlm.nih.gov/pubmed/32957336 http://dx.doi.org/10.1097/MD.0000000000022137 |
Ejemplares similares
-
The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori: Erratum
Publicado: (2021) -
Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections
por: Ahn, Hyo Jun, et al.
Publicado: (2017) -
Evaluation of prognostic factor and nature of acute esophageal necrosis: Restropective multicenter study
por: Kim, Sun Moon, et al.
Publicado: (2019) -
Probiotics for Standard Triple Helicobacter pylori Eradication: A Randomized, Double-blind, Placebo-controlled Trial
por: Hauser, Goran, et al.
Publicado: (2015) -
Seven-day triple therapy is sufficient to eradicate infection caused by Helicobacter pylori without 23S rRNA point mutation
por: Lee, Jung Wook, et al.
Publicado: (2021)